Syphilis in Pregnancy
Description Diagnosis General measures Medicine treatment Referral (baby) O98.1 DESCRIPTION A sexually transmitted infection with many manifestations that has a latent phase and may be asymptomatic in pregnant women. It is caused by the spirochaete, T pallidum . Vertical transmission to the foetus occurs in up to 80% of cases in untreated mothers. Untreated maternal syphilis may lead to miscarria
Description
Diagnosis
General measures
Medicine treatment
Referral (baby)
O98.1
DESCRIPTION
A sexually transmitted infection with many manifestations that has a latent phase and may be asymptomatic in pregnant women. It is caused by the spirochaete, T pallidum. Vertical transmission to the foetus occurs in up to 80% of cases in untreated mothers. Untreated maternal syphilis may lead to miscarriage, stillbirth, non-immune hydrops fetalis, or congenital syphilis in the newborn.
DIAGNOSIS
- All pregnant women should have a syphilis test at the first booking visit.
- Women who booked in the first trimester and tested negative should have a repeat test done around 32 weeks' gestation.
- Diagnosis is made by positive serology. Clinical signs and symptoms are most recognisable in secondary syphilis. These include rash on palms of the hand and/or soles of the feet; and condylomata lata on genital areas.
- There are 2 types of diagnostic tests:
| Specific treponemal test (e.g. TPAb//TPHA/FTA-ABS): |
Non-treponemal test (e.g. RPR): |
|
- Specifically diagnoses syphilis |
The RPR can be used: - To determine if the patient's syphilis disease is active or not, Note: - False RPR positive reactions may occur, notably in patients with connective tissue disorders (these are usually low titre <1:8). For this reason, positive RPR results should be confirmed as due to syphilis by further testing of the serum with a specific treponemal test; if the specific test result cannot be obtained the same day, start treatment while awaiting the result. |
GENERAL MEASURES
- Encourage partner notification and treatment after confirming the diagnosis.
- Provide counselling and promote HIV testing.
- Educate on treatment adherence.
- Promote condom use.
MEDICINE TREATMENT
Pregnant woman
- Benzathine benzylpenicillin, IM, 2.4 MU weekly for 3 weeks.
- Reconstitute with 6 mL of lidocaine 1% without adrenaline (epinephrine).
- Follow up at 3 months after the last injection to confirm a fourfold (i.e. 2 dilution) reduction in RPR titres, provided the initial titre was ≥ 1:8. If initial titre < 1:8, further reductions may not occur (serofast reaction).
LoE:IVb27
Severe penicillin allergy:
Z88.0
Refer for in-patient penicillin desensitisation.
Newborn baby
If baby asymptomatic, well and mother not fully treated > 1 month before delivery, give:
- Benzathine benzylpenicillin (depot formulation), IM, 50 000 units/kg as a single dose into the lateral thigh.
Caution:
Benzathine benzylpenicillin (depot formulation) must never be given intravenously.
REFERRAL (BABY)
- Mother was not treated
- Mother has received < 3 doses of benzathine benzylpenicillin
- Mother delivered within 4 weeks of commencing treatment
- Baby has any of the following:
- Hepatosplenomegaly
- Pseudoparesis
- Snuffles
- Oedema
- Jaundice
- Anaemia
- Purpura
- Desquamative rash (especially involving palms and soles)
Standard Treatment Guidelines and Essential Medicines List for South Africa, Primary Healthcare, 2025-9_Version 1.0_26 March 2026
Chapter 6: Obstetrics and Gynaecology_6.4.4 Syphilis in Pregnancy